» Articles » PMID: 31892223

Comparative Structural Analysis of Different Mycobacteriophage-Derived Mycolylarabinogalactan Esterases (Lysin B)

Overview
Journal Biomolecules
Publisher MDPI
Date 2020 Jan 2
PMID 31892223
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Mycobacteriophage endolysins have emerged as a potential alternative to the current antimycobacterial agents. This study focuses on mycolylarabinogalactan hydrolase (LysB) enzymes of the α/β-hydrolase family, which disrupt the unique mycolic acid layer of mycobacterium cell wall. Multiple sequence alignment and structural analysis studies showed LysB-D29, the only enzyme with a solved three-dimensional structure, to share several common features with esterases (lacking lid domain) and lipases (acting on long chain lipids). Sequence and structural comparisons of 30 LysB homology models showed great variation in domain organizations and total protein length with major differences in the loop-5 motif harboring the catalytic histidine residue. Docking of different -nitrophenyl ligands (C4-C18) to LysB-3D models revealed that the differences in length and residues of loop-5 contributed towards wide diversity of active site conformations (long tunnels, deep and superficial funnels, shallow bowls, and a narrow buried cave) resembling that of lipases, cutinases, and esterases. A set of seven LysB enzymes were recombinantly produced; their activity against -nitrophenyl esters could be related to their active site conformation and acyl binding site. LysB-D29 (long tunnel) showed the highest activity with long chain -nitrophenyl palmitate followed by LysB-Omega (shallow bowl) and LysB-Saal (deep funnel).

Citing Articles

Mining versatile feruloyl esterases: phylogenetic classification, structural features, and deep learning model.

Guo L, Dong Y, Zhang D, Pan X, Jin X, Yan X Bioresour Bioprocess. 2025; 12(1):7.

PMID: 39878830 PMC: 11780051. DOI: 10.1186/s40643-024-00835-8.


Discovery and characterization of a novel LysinB from F2 sub-cluster mycobacteriophage RitSun.

Arora R, Nadar K, Bajpai U Sci Rep. 2024; 14(1):18073.

PMID: 39103410 PMC: 11300654. DOI: 10.1038/s41598-024-68636-9.


Unlocking prophage potential: and experimental analysis of a novel LysinB containing a peptidoglycan-binding domain.

Das R, Nadar K, Arora R, Bajpai U bioRxiv. 2024; .

PMID: 38405724 PMC: 10888907. DOI: 10.1101/2024.02.15.580446.


Exploring the Enzymatic and Antibacterial Activities of Novel Mycobacteriophage Lysin B Enzymes.

Abouhmad A, Korany A, Grey C, Dishisha T, Hatti-Kaul R Int J Mol Sci. 2020; 21(9).

PMID: 32365915 PMC: 7246905. DOI: 10.3390/ijms21093176.

References
1.
Derewenda Z, Derewenda U, Dodson G . The crystal and molecular structure of the Rhizomucor miehei triacylglyceride lipase at 1.9 A resolution. J Mol Biol. 1992; 227(3):818-39. DOI: 10.1016/0022-2836(92)90225-9. View

2.
Egmond M, de Vlieg J . Fusarium solani pisi cutinase. Biochimie. 2000; 82(11):1015-21. DOI: 10.1016/s0300-9084(00)01183-4. View

3.
Lai M, Liu C, Jiang S, Soo P, Tu M, Lee J . Antimycobacterial Activities of Endolysins Derived From a Mycobacteriophage, BTCU-1. Molecules. 2015; 20(10):19277-90. PMC: 6332426. DOI: 10.3390/molecules201019277. View

4.
Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

5.
Falagas M, Karageorgopoulos D . Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis. 2008; 46(7):1121-2. DOI: 10.1086/528867. View